SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-006905
Filing Date
2023-03-16
Accepted
2023-03-16 16:23:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20230315_defa14a.htm DEFA14A 15140
2 page1.jpg GRAPHIC 338878
3 page2.jpg GRAPHIC 375149
4 page3.jpg GRAPHIC 359365
5 page4.jpg GRAPHIC 424166
  Complete submission text file 0001437749-23-006905.txt   2079092
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 23739143
SIC: 2834 Pharmaceutical Preparations